PPARG and glioma: Twostudies [20, 25] showed that ciglitazone, a TZD PPAR-γ agonist, was toxic to glioma cells as well asto primary astrocytes, whereas in a third study [27] no toxicity was induced byciglitazone in normal astrocytes after eight days of incubation.